ºÚÁϳԹÏ×ÊÔ´

1.         Poli A, Wang J, Domingues O, Yan T, Thuen M, Thorsen F, Rygh CB, McCormack E, Fischer W, Planaguma J, Hentges F, Pedersen PH, Zimmer J, Enger PØ, and Chekenya M. Targeting NG2 with mAb9.2.27 activated NK-cells promotes microglial cytotoxicity against GBM, prolonging survival in rats (Co-first author, Oncotarget. 2013 Sep;4(9):1527-46)

2.         Skeie BS, Wang J, Dodoo E, Heggdal JI, Grønli J, Sleire L, Bragstad S, Chekenya M, Mørk S, Pedersen PH, Enger PØ, and Ganz JC. Gamma Knife Surgery as monotherapy with clinically relevant doses Prolongs Survival in a Human GBM Xenograft Model. (Biomed Res Int. 2013;2013:139674. doi: 10.1155/2013/139674. Epub 2013 Nov 10).

3.         Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, Wang J, Huszthy PC, Prestegarden L, Skaftnesmo KO, Brekka N, Nigro J, Lund-Johansen M, Mørk S, Enger PØ, Bjerkvig R and MiletiC H. EGFR activation promotes invasion and tumor development independent of angiogenesis. (Acta Neuropathologica, Epub 2013 Feb 22)

4.         Klink B, Miletic H, Stieber D, Huszthy P, Valenzuela JAC, Balss J, Wang J, Schubert M, Sakariassen PØ, Sundstrøm T, Torsvik A, Aarhus M, Mahesparan R, Deimling AV, Kaderali L, Niclou S, Schröck E, Bjerkvig R, Nigro J. A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1. (Plos one, Epub 2013 Mar 19)

5.         Jacobsen HK, Sleire L, Wang J, Netland IA, Mutlu E, Førde H, Pedersen PH, Gullberg Dand Enger PØ. Establishment of a novel dsRed NOD/Scid mouse strain to investigate the host and tumor cell compartments. (Cancer investigation, 2013 May;31(4):221-30)

6.         Kim DK, Wang J, Willingham SB, Martin R, Wernig G, and Weissman IL. Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia. 2012 May 30. doi: 10.1038/leu.2012.140. [Epub ahead of print]

7.         Viel T, Talasila T, Talasila KM, Monfared P, Wang J, Jikeli JfF, Waerzeggers Y, Neumaier B, Backes H, Brekka N, Thorsen F, Stieber D, Niclou SP, Winkeler A, Tavitian B, Hoehn M, Bjerkvig R, Miletic H, and Jacobs A. Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multi-modal µPET and µMRI. J Nucl Med. 2012 Jul;53(7):1135-45. Epub 2012 Jun 11.

8.         Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PO, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL. CD47 Is A Therapeutic Target On Human Solid Tumor Cells. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7. Epub 2012 Mar 26.

9.         Moen I, Jevne C, Wang J, Kalland KH, Chekenya M, Akslen LA, Sleire L, Enger PØ, Reed RK, Øyan AM and Stuhr L. Tumor-stroma interactions in red 4T1 mammary tumors in green mice with and without enhanced oxygenation. BMC Cancer. 2012 Jan 17;12:21.

10.       Yan T, Skaftnesmo KO, Leiss L, Sleire L, Wang J, Li XG, Enger PO. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. BMC Cancer. 2011 Dec 20;11:524.

11.       Wang J, Svendsen A, Kmiecik J, Miletic H, Immervoll H, Planaguma J, Bjerkvig R, Enger PØ, Rygh CB,  Chekenya M. Targeting the NG2 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. (PLoS One. 2011;6(7):e23062. Epub 2011 Jul 29).

12.       Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SAA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, Miletic H, Wang J, Stuhr L, Moen I, Brekke C, Bjerkvig B and Niclou1 SP. Bevacizumab reduces blood flow and increases tumor cell invasion in glioblastomas. Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3749-54.

13.       Wang J, Daphu I, Pedersen PH, Miletic H, Hovland R, Mørk S, Bjerkvig R, Tiron C, McCormack E, Micklem D, Lorens JB, Immervoll H, Thorsen F. A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients. Neuropathol Appl Neurobiol. 2011 Feb;37(2):189-205.

14.       Goplen D, Bougnaud S, Rajcevic U, Bøe SO, Skaftnesmo KO, Voges J, Enger PO, Wang J, Tysnes BB, Laerum OD, Niclou S, Bjerkvig R. {alpha}B-Crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells. Am J Pathol. 2010 Oct;177(4):1618-28. Epub 2010 Sep 2.

15.       Prestegarden L, Svendsen A, Wang J, Sleire L, Skaftnesmo KO, Bjerkvig R, Yan T, Askland L, Persson A, Sakariassen PØ, Enger PØ. Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Res. 2010 Jun 1; 70(11): 4274-9.

16.       Huszthy PC, Immervoll H, Wang J, Goplen D, Miletic H, Eide GE, Bjerkvig R. Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment. Gene Ther. 2010 Feb; 17(2): 202-16.

17.       Wang J, Miletic H, Per Ø Sakariassen, Peter C Huszthy, Hege Jacobsen, Narve Brekka, Xingang Li, Peng Zhao, Sverre Mørk, Martha Chekenya, Rolf Bjerkvig and Per Ø Enger. A standardised brain tumor model established from the human glioblastoma multiforme biopsies. BMC Cancer. 2009 Dec 29; 9:465.

18.       Thulin Ã…, Ringvall M, Dimberg A, KÃ¥rehed K, Väisänen T, Väisänen MR, Hamad O, Wang J, Bjerkvig R, Nilsson B, Pihlajaniemi T, Ã…kerud H, Pietras K, Jahnen-Dechent W, Siegbahn A, Olsson AK. Activated platelets provide a functional microenvironment for the anti-angiogenic fragment of histidine-rich glycoprotein. Mol Cancer Res. 2009 Nov; 7(11): 1792-802. Epub 2009 Nov 10.

19.       Rajcevic U, Petersen K, Knol JC, Loos M, Bougnaud S, Klychnikov O, Li KW, Pham TV, Wang J, Miletic H, Peng Z, Bjerkvig R, Jimenez CR, Niclou SP. iTRAQ based proteomic profiling reveals increased metabolic activity and cellular crosstalk in angiogenic compared to invasive Glioblastoma phenotype. Mol Cell Proteomics. 2009 Nov;8(11): 2595-612. Epub 2009 Aug 12.

20.      Johannessen TC, Wang J, Skaftnesmo KO, Sakariassen PØ, Enger PØ, Petersen K, Øyan AM, Kalland KH, Bjerkvig R, Tysnes BB. Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype. Neuropathol Appl Neurobiol. 2009 Aug; 35(4): 380-93.

21.       Thorsen F, Jirak D, Wang J, Sykova E, Bjerkvig R, Enger PØ, van der Kogel A, Hajek M. Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics. NMR Biomed. 2008 Oct; 21(8): 830-8.

22.       Chekenya M, Krakstad C, Svendsen A, Netland IA, Staalesen V, Tysnes BB, Selheim F, Wang J, Sakariassen PØ, Sandal T, Lønning PE, Flatmark T, Enger PØ, Bjerkvig R, Sioud M, Stallcup WB. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene. 2008 Sep 4; 27(39): 5182-94. Epub 2008 May 12.

23.       Huszthy PC, Goplen D, Thorsen F, Immervoll H, Wang J, Gutermann A, Miletic H, Bjerkvig R. Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma. Clin Cancer Res. 2008 Mar 1; 14 (5): 1571-80.

24.       Wang J, Sakariassen PØ, Tsinkalovsky O, Immervoll H, Bøe SO, Svendsen A, Prestegarden L, Røsland G, Thorsen F, Stuhr L, Molven A, Bjerkvig R, Enger PØ. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer. 2008 Feb 15; 122 (4):761-8.

25.       Sakariassen PØ, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Øyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger PØ. Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci U S A. 2006 Oct 31;103 (44):16466-71. Epub 2006 Oct 20.

26.       Goplen D, Wang J, Enger PØ, Tysnes BB, Terzis AJ, Laerum OD, Bjerkvig R. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res. 2006 Oct 15; 66 (20): 9895-902.

27.       Thorsen F, Enger PØ, Wang J, Bjerkvig R, Pedersen PH. Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery. J Neurooncol. 2007 Mar; 82 (1): 1-10. Epub 2006 Sep 6.

28.       Sundlisaeter E, Wang J, Sakariassen PØ, Marie M, Mathisen JR, Karlsen BO, Prestegarden L, Skaftnesmo KO, Bjerkvig R, Enger PØ. Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation. Neuropathol Appl Neurobiol. 2006 Aug; 32 (4): 419-27.

29.       Piepoli T, Jakupoglu C, Gu W, Lualdi E, Suarez-Merino B, Poliani PL, Cattaneo MG, Ortino B, Goplen D, Wang J, Mola R, Inverardi F, Frassoni C, Bjerkvig R, Steinlein O, Vicentini LM, Brüstle O, Finocchiaro G. Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. Neuro Oncol. 2006 Apr; 8(2): 96-108. Epub 2006 Mar 2.

Book chapter: Wang, J. Terzis. A.J.A, Aboody, K. Enger, PO and Bjerkvig, R. Transplants for Glioblastoma In Cell Transplantation from Laboratory to Clinic, Elsevier Publishers, C. Halberstadt and D. Emerich eds. (2007)